• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prevalence and Characteristics of Pulmonary Hypertension Associated with COPD - A Pilot Study in Patients Referred to a Pulmonary Rehabilitation Program Clinic.慢性阻塞性肺疾病相关肺动脉高压的患病率及特征——一项针对转诊至肺康复项目诊所患者的初步研究
Maedica (Bucur). 2013 Sep;8(3):243-8.
2
Pulmonary hypertension secondary to chronic obstructive pulmonary disease.慢性阻塞性肺疾病所致的肺动脉高压
Rom J Intern Med. 2012 Oct-Dec;50(4):259-68.
3
Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease.阻塞性睡眠呼吸暂停对慢性阻塞性肺疾病患者肺动脉高压的影响。
Chin Med J (Engl). 2019 Jun 5;132(11):1272-1282. doi: 10.1097/CM9.0000000000000247.
4
Pulmonary hypertension in a stable community-based COPD population.稳定的社区 COPD 人群中的肺动脉高压。
Lung. 2011 Oct;189(5):377-82. doi: 10.1007/s00408-011-9315-2. Epub 2011 Aug 4.
5
Echocardiographic evaluation of heart in chronic obstructive pulmonary disease patient and its co-relation with the severity of disease.慢性阻塞性肺疾病患者心脏的超声心动图评估及其与疾病严重程度的相关性。
Lung India. 2011 Apr;28(2):105-9. doi: 10.4103/0970-2113.80321.
6
Right ventricular dysfunction and remodeling in chronic obstructive pulmonary disease without pulmonary hypertension.慢性阻塞性肺疾病患者中无肺动脉高压时的右心室功能障碍和重构。
J Am Coll Cardiol. 2013 Sep 17;62(12):1103-1111. doi: 10.1016/j.jacc.2013.04.091. Epub 2013 Jul 10.
7
[Follow-up study of patients with chronic obstructive pulmonary disease complicated with pulmonary hypertension].慢性阻塞性肺疾病合并肺动脉高压患者的随访研究
Zhonghua Jie He He Hu Xi Za Zhi. 2021 Aug 12;44(8):717-722. doi: 10.3760/cma.j.cn112147-20201013-01038.
8
Comparison of the Factors Influencing Pulmonary Arterial Pressure in Smoker and Non-smoker COPD Patients with Pulmonary Hypertension.吸烟与不吸烟的慢性阻塞性肺疾病合并肺动脉高压患者肺动脉压影响因素的比较
Tanaffos. 2019 Jan;18(1):41-46.
9
[Pulmonary hypertension in patients with chronic obstructive pulmonary disease: clinical characteristics and risk factors].[慢性阻塞性肺疾病患者的肺动脉高压:临床特征与危险因素]
Zhonghua Nei Ke Za Zhi. 2015 Dec;54(12):1037-40.
10
Speckle Tracking Echocardiography to Evaluate for Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease.斑点追踪超声心动图评估慢性阻塞性肺疾病中的肺动脉高压
COPD. 2016 Oct;13(5):595-600. doi: 10.3109/15412555.2015.1134468. Epub 2016 Feb 1.

引用本文的文献

1
Drugs targeting the NO-sGC-cGMP pathway in the treatment of patients with COPD-associated pulmonary hypertension: a systematic review.靶向一氧化氮-可溶性鸟苷酸环化酶-环磷酸鸟苷途径的药物治疗慢性阻塞性肺疾病相关肺动脉高压患者的系统评价
Front Pharmacol. 2025 Sep 5;16:1641932. doi: 10.3389/fphar.2025.1641932. eCollection 2025.
2
The Saudi Thoracic Society Evidence-based guidelines for the diagnosis and management of chronic obstructive pulmonary disease.沙特胸科学会慢性阻塞性肺疾病诊断与管理的循证指南
Ann Thorac Med. 2025 Jan-Mar;20(1):1-35. doi: 10.4103/atm.atm_155_24. Epub 2024 Sep 24.
3
Clinical insights into pulmonary hypertension in chronic obstructive pulmonary disease.慢性阻塞性肺疾病中肺动脉高压的临床见解
Pulm Circ. 2022 Jan 3;12(1):e12006. doi: 10.1002/pul2.12006. eCollection 2022 Jan.
4
Impact of pulmonary hypertension in patients with acute exacerbation of chronic obstructive pulmonary disease and its effect on healthcare utilization.肺动脉高压对慢性阻塞性肺疾病急性加重患者的影响及其对医疗资源利用的作用。
Pulm Circ. 2021 Sep 24;11(4):20458940211046838. doi: 10.1177/20458940211046838. eCollection 2021 Oct-Dec.
5
Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases.用于非慢性阻塞性肺疾病呼吸系统疾病的磷酸二酯酶-4抑制剂
Front Pharmacol. 2021 Aug 5;12:518345. doi: 10.3389/fphar.2021.518345. eCollection 2021.
6
Mean platelet volume as a predictor of pulmonary hypertension in patients with stable COPD.平均血小板体积作为稳定 COPD 患者肺动脉高压的预测因子。
Int J Chron Obstruct Pulmon Dis. 2019 May 23;14:1099-1108. doi: 10.2147/COPD.S176413. eCollection 2019.
7
Prevalence of pulmonary artery hypertension in patients of chronic obstructive pulmonary disease and its correlation with stages of chronic obstructive pulmonary disease, exercising capacity, and quality of life.慢性阻塞性肺疾病患者肺动脉高压的患病率及其与慢性阻塞性肺疾病分期、运动能力和生活质量的相关性。
J Family Med Prim Care. 2018 Jan-Feb;7(1):53-57. doi: 10.4103/jfmpc.jfmpc_18_17.
8
Comparison and evaluation of two different methods to establish the cigarette smoke exposure mouse model of COPD.两种不同方法建立慢性阻塞性肺疾病香烟烟雾暴露小鼠模型的比较与评价
Sci Rep. 2017 Nov 13;7(1):15454. doi: 10.1038/s41598-017-15685-y.
9
Pulmonary artery enlargement is associated with right ventricular dysfunction and loss of blood volume in small pulmonary vessels in chronic obstructive pulmonary disease.肺动脉扩大与慢性阻塞性肺疾病中右心室功能障碍及小肺血管血容量减少有关。
Circ Cardiovasc Imaging. 2015 Apr;8(4). doi: 10.1161/CIRCIMAGING.114.002546.

本文引用的文献

1
Frequency of pulmonary hypertension in patients with COPD due to biomass smoke and tobacco smoke.生物燃料烟雾和烟草烟雾所致 COPD 患者的肺动脉高压频率。
Int J Med Sci. 2012;9(6):406-12. doi: 10.7150/ijms.4715. Epub 2012 Jul 21.
2
Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease.与终末期慢性阻塞性肺疾病相关的肺动脉高压的患病率、预测因素和生存率。
J Heart Lung Transplant. 2012 Apr;31(4):373-80. doi: 10.1016/j.healun.2011.11.020. Epub 2012 Jan 9.
3
Echocardiographic evidence of pulmonary hypertension is associated with increased 1-year mortality in patients admitted with chronic obstructive pulmonary disease.超声心动图显示肺动脉高压与慢性阻塞性肺疾病患者住院 1 年内死亡率升高相关。
Lung. 2011 Jun;189(3):207-12. doi: 10.1007/s00408-011-9293-4. Epub 2011 May 10.
4
Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography.成人右心超声心动图评估指南:美国超声心动图学会报告,得到欧洲心脏病学会注册分支欧洲超声心动图协会以及加拿大超声心动图学会认可。
J Am Soc Echocardiogr. 2010 Jul;23(7):685-713; quiz 786-8. doi: 10.1016/j.echo.2010.05.010.
5
Update on pulmonary hypertension complicating chronic obstructive pulmonary disease.慢性阻塞性肺疾病并发肺动脉高压的最新进展。
Int J Chron Obstruct Pulmon Dis. 2009;4:351-63. doi: 10.2147/copd.s5102. Epub 2009 Sep 24.
6
Guidelines for the diagnosis and treatment of pulmonary hypertension.肺动脉高压诊断与治疗指南。
Eur Respir J. 2009 Dec;34(6):1219-63. doi: 10.1183/09031936.00139009. Epub 2009 Sep 12.
7
Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.慢性阻塞性肺疾病和间质性肺疾病中的肺动脉高压
Semin Respir Crit Care Med. 2009 Aug;30(4):458-70. doi: 10.1055/s-0029-1233315. Epub 2009 Jul 24.
8
Updated clinical classification of pulmonary hypertension.肺动脉高压的更新临床分类。
J Am Coll Cardiol. 2009 Jun 30;54(1 Suppl):S43-S54. doi: 10.1016/j.jacc.2009.04.012.
9
Pulmonary hypertension in patients with chronic obstructive pulmonary disease: advances in pathophysiology and management.慢性阻塞性肺疾病患者的肺动脉高压:病理生理学与管理进展
Drugs. 2009 Jun 18;69(9):1153-71. doi: 10.2165/00003495-200969090-00002.
10
Pulmonary vascular involvement in COPD.慢性阻塞性肺疾病中的肺血管受累情况。
Chest. 2008 Oct;134(4):808-814. doi: 10.1378/chest.08-0820.

慢性阻塞性肺疾病相关肺动脉高压的患病率及特征——一项针对转诊至肺康复项目诊所患者的初步研究

Prevalence and Characteristics of Pulmonary Hypertension Associated with COPD - A Pilot Study in Patients Referred to a Pulmonary Rehabilitation Program Clinic.

作者信息

Gologanu Daniela, Stanescu Cristina, Ursica Teodora, Balea Marius I, Ionita Diana, Bogdan Miron Alexandru

机构信息

Laboratory of Respiratory Diseases Research, CDPC; Colentina Clinical Hospital.

Department of Cardiology, Colentina Clinical Hospital ; "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.

出版信息

Maedica (Bucur). 2013 Sep;8(3):243-8.

PMID:24371492
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3869112/
Abstract

OBJECTIVES

Pulmonary hypertension (PH) is a common complication of chronic obstructive pulmo-nary disease (COPD); its prevalence is currently unknown. The objectives of the study were: (a) to provide data on the prevalence of PH among the COPD patients referred to a pulmonary rehabilitation program; (b) to evaluate possible correlations of PH with the severity of COPD, the presence of hypoxemia and polycythemia.

MATERIAL AND METHODS

We retrospectively studied 31 consecutive patients with the diagnosis of COPD hospitalised in our clinic in which echocardiography was performed. Spirometry, peripheral oxygen saturation, haematocrit, echocardiography data, history of exacerbations and cardiac comorbidities were obtained from patients records. PH was defined as systolic pulmonary arterial pressure (sPAP) greater than 35 mmHg or by the presence of right ventricle (RV) abnormalities.

OUTCOMES

The prevalence of PH was 38.7%. Resting hypoxemia was significantly more frequent in the PH group than in the non PH patients (p=0.019). Other differences were not statistically significant (severity of bronchial obstruction and polycythemia, cardiac comorbidities). The impact of PH on RV was found in only 5 patients with RV enlargement; no patient had RV hypertrophy or RV systolic dysfunction. Suspected "out of proportion" PH (sPAP greater than 50 mmHg) was encountered in 2 out of 12 patients with PH.

CONCLUSIONS

The prevalence of PH in patients with COPD was 38.7%. Resting hypoxemia was significantly more frequent in PH patients. As PH has an important role in the prognosis of COPD patients, it should be evaluated in as many COPD patients as possible.

摘要

目的

肺动脉高压(PH)是慢性阻塞性肺疾病(COPD)的常见并发症;其患病率目前尚不清楚。本研究的目的是:(a)提供参加肺康复计划的COPD患者中PH患病率的数据;(b)评估PH与COPD严重程度、低氧血症和红细胞增多症之间的可能相关性。

材料与方法

我们回顾性研究了在我院住院并接受超声心动图检查的31例连续诊断为COPD的患者。从患者记录中获取肺活量测定、外周血氧饱和度、血细胞比容、超声心动图数据、病情加重史和心脏合并症。PH定义为收缩期肺动脉压(sPAP)大于35 mmHg或存在右心室(RV)异常。

结果

PH患病率为38.7%。PH组静息低氧血症的发生率显著高于非PH患者(p = 0.019)。其他差异无统计学意义(支气管阻塞严重程度和红细胞增多症、心脏合并症)。仅在5例RV扩大的患者中发现PH对RV的影响;无患者出现RV肥厚或RV收缩功能障碍。12例PH患者中有2例出现疑似“不成比例”的PH(sPAP大于50 mmHg)。

结论

COPD患者中PH的患病率为38.7%。PH患者静息低氧血症的发生率显著更高。由于PH在COPD患者的预后中具有重要作用,应尽可能对更多的COPD患者进行评估。